Master Alliance Provisions Guide (MAPGuide)

Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement

  • Business model | Regulatory strategy

1. Object and Territory


1.6.3 Within up to thirty (30) days from the present date, the Parties shall enter into Exhibit VI – Regulatory Activities Agreement, with the objective of, among others, disciplining the interaction of the Parties in relation to the Covid-19 Vaccine registration strategy with the National Agency Health Surveillance (“ANVISA).